...
首页> 外文期刊>Medicine. >Familial mediterranean fever: Risk factors, causes of death, and prognosis in the colchicine era
【24h】

Familial mediterranean fever: Risk factors, causes of death, and prognosis in the colchicine era

机译:家族性地中海热:秋水仙碱时代的危险因素,死亡原因和预后

获取原文
获取原文并翻译 | 示例

摘要

We assessed the risk factors and causes of death in patients with familial Mediterranean fever (FMF) in an era when colchicine is the standard therapy for all patients.This study included all FMF patients who had presented to any of the internal medicine, rheumatology, or nephrology clinics at Dokuz Eylul University Hospital between 1992 and 2009. Of the 650 patients with FMF identified, 587 (90.3%) had either a face-to-face (n = 380) or telephone (n = 193) interview, or were confirmed as deceased. A structured questionnaire was used to obtain socioeconomic and demographic data, presenting and cumulative clinical features, and disease severity scores.During the follow-up period mortality was analyzed by calculating age- and sex-standardized mortality ratio (SMR) according to the mortality statistics of the Turkish population. Factors predictive of mortality were evaluated using Kaplan-Meier and Cox proportional hazard models. Sixty-three (9.7%) patients whose initial demographic and major clinical characteristics were similar to the rest of the group could not be contacted during the study period.Most (94.2%) patients were on colchicine at the time of the study. Thirty-seven (6.3%) patients had biopsy-verified amyloidosis, and 44 (7.5%) had renal disease. During a median follow-up of 6 years, 14 patients (9 women) died, and amyloidosis and its related complications were the leading causes of death in 7 patients. Univariate analysis revealed that increasing age, coronary heart disease, hypertension, renal disease, and amyloidosis were associated with mortality. However, Cox regression analysis showed amyloidosis as the only significant predictor of mortality (p < 0.001). The overall patient survival rate was not significantly different from the age- and sex-matched Turkish general population (SMR, 1.48; 95% confidence interval, 0.817-2.49).Our findings suggest that although the survival of FMF patients in the colchicine era is comparable to that of the general population, renal involvement still predicts mortality.
机译:我们评估了秋水仙碱为所有患者的标准疗法时代的家族性地中海热(FMF)患者的危险因素和死亡原因,该研究包括所有曾接受过内科,风湿病或内科治疗的FMF患者在1992年至2009年之间,在Dokuz Eylul大学医院的肾脏病诊所就诊。在确定的650名FMF患者中,有587名(90.3%)进行了面对面(n = 380)或电话(n = 193)的采访,或得到了证实死者使用结构化调查表获取社会经济和人口统计学数据,呈现和累积的临床特征以及疾病严重程度评分;在随访期间,根据死亡率统计数据通过计算年龄和性别标准化死亡率(SMR)分析死亡率土耳其人口。使用Kaplan-Meier和Cox比例风险模型评估了预测死亡率的因素。在研究期间无法联系其初始人口统计学和主要临床特征与该组其他患者相似的六十三(9.7%)名患者。在研究时,大多数(94.2%)患者接受秋水仙碱治疗。三十七名(6.3%)患者经活检证实为淀粉样变性,而44名(7.5%)患者患有肾脏疾病。在6年的中位随访期间,有14例患者(9名妇女)死亡,淀粉样变性及其相关并发症是7例患者的主要死亡原因。单因素分析表明,年龄增长,冠心病,高血压,肾脏疾病和淀粉样变性与死亡率相关。但是,Cox回归分析显示淀粉样变性是死亡率的唯一重要预测指标(p <0.001)。总体患者存活率与年龄和性别相匹配的土耳其普通人群并无显着差异(SMR,1.48; 95%置信区间,0.817-2.49)。我们的研究结果表明,尽管秋水仙碱时代的FMF患者的存活率是与普通人群相比,肾脏受累仍可预测死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号